Pharmalicensing Ltd, a division of UTEK Corporation (AMEX & AIM: UTK) is pleased to announce that it has entered into an agreement with the Zangani Investor Community™ to sponsor the forthcoming Zangani Pharma Finance 2008 conference in Rome, 22/23 May.

“We are delighted to be working with Zangani Investor Community™ and to be sponsoring the Pharma Finance 2008 conference,” said Mark McBride, Director of Pharmalicensing Ltd and Vice President of UTEK Corporation, “we feel that such clearly defined events support and enable collaboration and partner development within the international life science community”

Pharma Finance 2008 is the only fully dedicated event in Italy focusing on intellectual property exchanges, licensing, strategic alliance, and marketing.

Pharmalicensing.com (www.pharmalicensing.com) is the world’s leading life science exchange for open innovation and investment opportunities for the international biopharmaceutical industry.

Offering partnering and licensing support to pharmaceutical business development professionals around the world, Pharmalicensing.com is utilised by over 100,000 life science professionals a month as a key identifier of innovative partnering clients and investment/deal making intelligence.

Pharmalicensing Ltd is a division of UTEK Corporation, and an integral part of UTEK’s full suite of Open Innovation services including innovative strategic consulting, external sourcing of new technologies, external sourcing of new development projects and intellectual property analysis (patent analytics). For further information please go to www.utekcorp.com.